Corporate Overview

Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) is a late-stage biopharmaceutical company focused on the development and commercialization of first-in-class critical care products, with a pipeline of anti-infectives in adjunct cancer care, oncology, stem cell therapy and unique prescription products.

Read more

Why Invest

5

Diversified Pipeline Candidates

$26.5M

Invested by Founders

$1.8B

Worldwide Sales Potential of Mino-Lok®

2022

Inflection Point for Value Driving Catalysts

Learn more

Latest News

View all news

Latest Presentation

Latest Events

View All Events

Latest Financial Reports

View All Financial Reports